• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次支架内血栓形成成功治疗后,支架内血栓复发的发生率较高。

High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.

作者信息

Lemesle Gilles, Sudre Arnaud, Modine Thomas, Delhaye Cédric, Rosey Guillaume, Gourlay Terry, Bauters Christophe, Lablanche Jean-Marc

机构信息

Service de Cardiologie B et Centre Hémodynamique, Hôpital cardiologique, CHRU de LILLE, 59037 Lille, France.

出版信息

Catheter Cardiovasc Interv. 2008 Oct 1;72(4):470-8. doi: 10.1002/ccd.21709.

DOI:10.1002/ccd.21709
PMID:18814219
Abstract

OBJECTIVES

We attempted to investigate incidence and predictors of recurrent in stent thrombosis (IST) after successful treatment of a first IST.

BACKGROUND

The occurrence of recurrent IST after successful treatment of a first IST may be a decisive factor for patient clinical outcome. However, incidence and predictors of recurrent IST are currently poorly described in the literature.

METHODS

Between 2003 and 2005, 2,190 patients underwent a percutaneous coronary intervention in our center. During a median follow-up of 19.4 months, 49 patients (2.24%) presented a first definite IST. Patients presenting with a first IST were followed during an additional median period of 40 months. Their baseline characteristics were listed and cardiovascular events especially recurrent IST as defined by the Academic Research Consortium definition were systematically indexed.

RESULTS

Altogether 39 (80%) patients were successfully treated with an effective reperfusion after percutaneous coronary intervention. Fourteen (36%) patients presented a recurrent IST and three presented multiple recurrent IST. The median occurrence time of recurrent IST was 5 days, range between 1 and 11 days. Multivariate analysis identified history of neoplasia (HR = 11.53, 95% CI 2.32-57.37, P = 0.003), residual diameter stenosis (HR = 1.15, 95% CI 1.02-1.29, P = 0.02), and residual dissection after treatment (HR = 8.78, 95% CI 1.85-41.62, P = 0.006), as independent predictors of recurrent IST.

CONCLUSION

Recurrent IST is a frequent and early event after successful treatment of a first IST. Our results suggest that mechanical factors like residual dissection and residual diameter stenosis should be carefully tracked down. In addition, patients with multiple recurrent IST and the early time course of recurrent IST also suggest a potential role of inadequate antiplatelet therapy.

摘要

目的

我们试图研究首次支架内血栓形成(IST)成功治疗后复发性IST的发生率及预测因素。

背景

首次IST成功治疗后复发性IST的发生可能是决定患者临床结局的一个因素。然而,目前文献中对复发性IST的发生率及预测因素描述甚少。

方法

2003年至2005年期间,我们中心有2190例患者接受了经皮冠状动脉介入治疗。在中位随访19.4个月期间,49例患者(2.24%)出现首次明确的IST。出现首次IST的患者在额外的中位40个月期间接受随访。列出他们的基线特征,并系统记录心血管事件,尤其是学术研究联盟定义的复发性IST。

结果

共有39例(80%)患者在经皮冠状动脉介入治疗后通过有效的再灌注成功治疗。14例(36%)患者出现复发性IST,3例出现多次复发性IST。复发性IST的中位发生时间为5天,范围在1至11天之间。多变量分析确定肿瘤病史(HR = 11.53,95% CI 2.32 - 57.37,P = )、残余直径狭窄(HR = 1.15,95% CI 1.02 - 1.29,P = 0.02)以及治疗后残余夹层(HR = 8.78,95% CI 1.85 - 41.62,P = 0.006)为复发性IST的独立预测因素。

结论

首次IST成功治疗后,复发性IST是一种常见且早期发生的事件。我们的结果表明,应仔细追查残余夹层和残余直径狭窄等机械因素。此外,多次复发性IST的患者以及复发性IST的早期病程也提示抗血小板治疗不足可能起了作用。 (注:原文中肿瘤病史HR值对应P值处缺失数据)

相似文献

1
High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.首次支架内血栓形成成功治疗后,支架内血栓复发的发生率较高。
Catheter Cardiovasc Interv. 2008 Oct 1;72(4):470-8. doi: 10.1002/ccd.21709.
2
Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.
J Cardiovasc Pharmacol Ther. 2007 Dec;12(4):298-303. doi: 10.1177/1074248407306671.
3
Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.氯吡格雷抵抗对药物洗脱支架经皮冠状动脉介入术后血栓形成事件的影响。
Thromb Res. 2009 May;124(1):46-51. doi: 10.1016/j.thromres.2008.10.007. Epub 2008 Nov 28.
4
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.采用 Multiplate 即时检验分析评估氯吡格雷反应状态与冠状动脉支架置入术后 6 个月内支架血栓形成的发生率和时间。
Thromb Haemost. 2010 Jan;103(1):151-9. doi: 10.1160/TH09-05-0284. Epub 2009 Oct 26.
5
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.西罗莫司洗脱支架在ST段抬高型心肌梗死中的临床影响:一项随机临床试验的荟萃分析
Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017.
6
Noncardiac surgery and bleeding after percutaneous coronary intervention.非心脏手术与经皮冠状动脉介入治疗后的出血。
Circ Cardiovasc Interv. 2009 Jun;2(3):213-21. doi: 10.1161/CIRCINTERVENTIONS.108.830158. Epub 2009 Apr 21.
7
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.术前高敏C反应蛋白可预测经皮冠状动脉介入治疗后的死亡或心肌梗死,但不能预测靶血管血运重建或支架血栓形成。
Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005.
8
Recurrent very late stent thrombosis after bare-metal stent implantation.裸金属支架植入术后复发性极晚期支架内血栓形成。
Catheter Cardiovasc Interv. 2007 Jul 1;70(1):51-3. doi: 10.1002/ccd.21044.
9
Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.紫杉醇洗脱支架的晚期血栓形成:604例患者队列中的长期发生率、临床后果及危险因素
Am Heart J. 2008 Apr;155(4):648-53. doi: 10.1016/j.ahj.2007.11.027. Epub 2008 Feb 21.
10
Stent thrombosis in the era of drug eluting stents.药物洗脱支架时代的支架内血栓形成
Minerva Cardioangiol. 2007 Apr;55(2):199-211.

引用本文的文献

1
Influence of Illness Uncertainty on Health Behavior in Individuals with Coronary Artery Disease: A Path Analysis.疾病不确定性对冠心病患者健康行为的影响:路径分析。
J Korean Acad Nurs. 2024 May;54(2):162-177. doi: 10.4040/jkan.23136.
2
Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗和冠状动脉支架置入患者支架内血栓形成的影响因素:一项系统评价和荟萃分析。
Cureus. 2022 Apr 9;14(4):e23973. doi: 10.7759/cureus.23973. eCollection 2022 Apr.
3
Recurrent Stent Thrombosis: An Interventionalist's Nightmare.
复发性支架内血栓形成:介入医生的噩梦。
J Am Heart Assoc. 2021 May 4;10(9):e020728. doi: 10.1161/JAHA.121.020728. Epub 2021 Apr 17.
4
The dawn of neurosurgery in pre-conquest Mesoamerican territories.征服前中美洲地区神经外科的开端。
Childs Nerv Syst. 2017 Oct;33(10):1621-1629. doi: 10.1007/s00381-017-3464-4. Epub 2017 Sep 6.
5
Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.经皮冠状动脉介入治疗后心绞痛复发:机制、诊断和治疗选择。
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):158-69. doi: 10.1177/2048872612449111.
6
Towards personalized medicine based on platelet function testing for stent thrombosis patients.基于血小板功能检测的支架血栓形成患者个性化医疗方案研究
Thrombosis. 2012;2012:617098. doi: 10.1155/2012/617098. Epub 2012 Dec 25.
7
[Coronary stent thrombosis: what's new in 2011?].
Herz. 2011 May;36(3):241-53. doi: 10.1007/s00059-011-3464-1.
8
Coronary stent thrombosis in the current era: challenges and opportunities for treatment.
Curr Treat Options Cardiovasc Med. 2010 Jan;12(1):46-57. doi: 10.1007/s11936-009-0055-z.